Anaesthetic management of a patient with myasthenia gravis for abdominal surgery using sugammadex

Archives of Medical Science

Volumn 7, Issue 2, 2011, Pages 361-364

  Rudzka Nowak, Alina ^a   Piechota, Mariusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Myasthenia gravis; Neuromuscular monitoring; Sugammadex; Vecuronium

Indexed keywords

DOXAZOSIN MESYLATE; FINASTERIDE; KETOPROFEN; METAZYDYNA; PENESTAN; PROPOFOL; PYRIDOSTIGMINE; REMIFENTANIL; SEVOFLURANE; SUGAMMADEX; TRIMETAZIDINE; UNCLASSIFIED DRUG; VECURONIUM; VICEBROL; VINPOCETINE; ZOXON;

AGED; ANESTHESIA INDUCTION; ARTICLE; ARTIFICIAL VENTILATION; BREATHING; CASE REPORT; CECUM TUMOR; CONTINUOUS INFUSION; EXTUBATION; GENERAL ANESTHESIA; HEMICOLECTOMY; HUMAN; MAINTENANCE DRUG DOSE; MALE; MYASTHENIA GRAVIS; NEUROMUSCULAR BLOCKING; POSTOPERATIVE ANALGESIA; RECOVERY ROOM; RESPIRATORY FUNCTION;

EID: 79956344413     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2011.22094     Document Type: Article

References (25)

1. Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis: past, present, and future. J Clin Invest 2006; 116: 2843-54. (Pubitemid 44684466)
2. Bachmann K, Burkhardt D, Schreiter I, et al. Thymectomy is more effective than conservative treatment for myasthenia gravis regarding outcome and clinical improvement. Surgery 2009; 145: 392-8.
3. Mincewicz G, Aloszko A, Nyka W, Bilińska M, Krzykowski G, Nyka WM. The comparison of selected spirometric parameters with functional muscles exercise evaluation in patients with myasthenia [Polish]. Pol Merkur Lek 2007; 22: 177-81.
4. Juel VC. Myasthenia gravis: management of myasthenic crisis and perioperative care. Semin Neurol 2004; 24: 75-81. (Pubitemid 38823781)
5. Dillon FX. Anesthesia issues in the perioperative management of myasthenia gravis. Semin Neurol 2004; 24: 83-94. (Pubitemid 38823782)
6. Haroun-Bizri S, Maalouli J, Deeb P, Baraka A. Anesthetic management for a patient with myasthenia gravis undergoing coronary artery bypass graft. Middle East J Anesthesiol 2003; 17: 299-305. (Pubitemid 38822375)
7. Heliopoulos I, Patlakas G, Vadikolias K, et al. Maximal voluntary ventilation in myasthenia gravis. Muscle Nerve 2003; 27: 715-9. (Pubitemid 36667481)
8. Bom A, Bradley M, Cameron K, et al. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl 2002; 41: 266-70.
9. Adam JM, Bennett DJ, Bom A, et al. Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structureactivity relationships. J Med Chem 2002; 45: 1806-16. (Pubitemid 34415376)
10. Tarver GJ, Grove SJ, Buchanan K, et al. 2-O-substituted cyclodextrins as reversal agents for the neuromuscular blocker rocuronium bromide. Bioorg Med Chem 2002; 10: 1819-27. (Pubitemid 34286374)
11. Cameron KS, Clark JK, Cooper A, et al. Modified gamma-cyclodextrins and their rocuronium complexes. Org Lett 2002; 4: 3403-6.
12. Unterbuchner C, Fink H, Blobner M. The use of sugammadex in a patient with myasthenia gravis. Anaesthesia 2010; 65: 302-5.
13. Cardone A, Congedo E, Aceto P, et al. Perioperative evaluation of myasthenia gravis. Ann Ital Chir 2007; 78: 359-65.
14. Cameron MH, Klein EL. Screening for medical disease-nervous system disorders. J Hand Ther 2010; 23: 158-71.
15. Blobner M, Mann R. Anesthesia in patients with myasthenia gravis. Anaesthesist 2001; 50: 484-93.
16. Viby-Mogensen J. Postoperative residual curarization and evidence-based anaesthesia. Br J Anaesth 2000; 84: 301-3. (Pubitemid 30114121)
17. McCaul C, Tobin E, Boylan JF, McShane AJ. Atracurium is associated with postoperative residual curarization. Br J Anaesth 2002; 89: 766-9. (Pubitemid 35277229)
18. Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology 2003; 98: 1042-8. (Pubitemid 36520189)
19. Flockton EA, Mastronardi P, Hunter JM, et al. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine. Br J Anaesth 2008; 100: 622-30. (Pubitemid 351774353)
20. Khuenl-Brady KS, Wattwil M, Vanacker BF, Lora-Tamayo JI, Rietbergen H, Alvarez-Gómez JA. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial. Anesth Analg 2010; 110: 64-73.
21. White PF, Tufanogullari B, Sacan O, et al. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex. Anesth Analg 2009; 108: 846-51.
22. Duvaldestin P, Kuizenga K, Saldien V, et al. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia. Anesth Analg 2010; 110: 74-82.
23. Dahl V, Pendeville PE, Hollmann MW, Heier T, Abels EA, Blobner M. Safety and efficacy of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery. Eur J Anaesthesiol 2009; 26: 874-84.
24. Weaver JM. New drugs on the horizon may improve the quality and safety of anesthesia. Anesth Prog 2008; 55: 27-8.
25. Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Analg 2007; 104: 575-81. (Pubitemid 46331731)